Fig. 5
- ID
- ZDB-FIG-180807-28
- Publication
- Sztal et al., 2018 - Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy
- Other Figures
- (all 6)
- All Figure Page
- Back to All Figure Page
Quantification of the phenotypic severity of neb ?/? mutants at 6 dpf. Quantification of the phenotypic severity of Tg(neb ?/? ; Lifeact-eGFP) fish at 6 dpf supplemented with either L-tyrosine, taurine, L-carnitine, creatine, or water (H2O). a Phenotypes were scored as either wildtype, mild (less than five Lifeact-eGFP positive aggregates at the myosepta or a mild disruption of muscle fibres), or severe (severely disorganised fibres or an accumulation of five or more Lifeact-eGFP positive aggregates within the muscle cell). b Quantification of the phenotypic severity of Tg(neb ?/? ; Lifeact-eGFP) fish supplemented with either L-tyrosine, taurine, or water. c Quantification of the phenotypic severity of Tg(neb ?/? ; Lifeact-eGFP) fish supplemented with either L-carnitine, creatine, or water (H2O). b & c Error bars represent mean±SEM for three independent experiments. For b) n =?6,8,7 Tg(neb ?/? ; Lifeact-eGFP) for L-tyrosine, n?=?11,5,11 Tg(neb ?/? ; Lifeact-eGFP) for taurine and n?=?9,8,10 Tg(neb ?/? ; Lifeact-eGFP) for water. For c) n?=?8,10,4 Tg(neb ?/? ; Lifeact-eGFP) for L-carnitine, n?=?6,8,3 Tg(neb ?/? ; Lifeact-eGFP) for creatine, and n =?10,9,5 Tg(neb ?/? ; Lifeact-eGFP) for water per experiment). ns?=?not significant |
Gene: | |
---|---|
Fish: | |
Anatomical Terms: | |
Stage: | Day 6 |
Fish: | |
---|---|
Observed In: | |
Stage: | Day 6 |